Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Nihon Chouzai Co's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was -25.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Nihon Chouzai Co's 3-Year ROIIC % or its related term are showing as below:
NHCZF's 3-Year ROIIC % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.46
vs NHCZF: -25.84
Nihon Chouzai Co (OTCPK:NHCZF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Nihon Chouzai Co 3-Year ROIIC % Related Terms
Nihon Chouzai Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Nihon Chouzai Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Chouzai Co 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Nihon Chouzai Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Chouzai Co 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nihon Chouzai Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Nihon Chouzai Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Nihon Chouzai Co (NHCZF) has a 3-Year ROIIC % of -25.84 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nihon Chouzai Co and its competitors.
Is Nihon Chouzai Co's 3-Year ROIIC % too high?
Nihon Chouzai Co's current 3-Year ROIIC % is -25.84. Overall, Nihon Chouzai Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's 3-Year ROIIC % compare to competitors?
Nihon Chouzai Co's 3-Year ROIIC % of -25.84 can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year ROIIC % is 3.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nihon Chouzai Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Chouzai Co's current 3-Year ROIIC % is -25.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (NHCZF) has a current 3-Year ROIIC % of -25.84. The stock's GF Value™ is $6.38, compared to a current price of $16.02 — trading 151.1% above its estimated fair value. The current 3-Year ROIIC % is -25.84. Nihon Chouzai Co's overall GF Score™ is 9/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Nihon Chouzai Co (NHCZF), the current 3-Year ROIIC % is -25.84 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Chouzai Co (NHCZF) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued.
The current stock price of $16.02 is trading 151.1% above its estimated GF Value™ of $6.38.
Key valuation signals for NHCZF:
3-Year ROIIC %: -25.84
GF Value™: $6.38 vs. price of $16.02 (151.1% above fair value)
No single metric tells the full story. See the NHCZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
9GF Score
Get the complete analysis for NHCZF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHCZF has been successfully added to your 
